Journey Medical CorporationDERM

$6.22+0.30 (+5.07%)
NASDAQHealthcare24:00 UTC

Company snapshot

Market Cap
$170M
Micro-cap
+91%
2021 — today
10-Year Price
-36%
2021 — today
52-Week Range
$4.39$9.26
Current $6.22· 38%

Journey Medical Corporation, a pharmaceutical firm established in Scottsdale, Arizona in 2014 (and previously known as Coronado Dermatology, Inc.), is dedicated to the development and market introduction of treatments for skin conditions across the United States. Their product line encompasses key dermatological therapies such as Qbrexza, a medicated cloth wipe for managing primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug for severe, persistent acne; Targadox, an oral doxycycline medication used as an additional treatment for severe acne; Ximino, an oral minocycline drug addressing moderate to severe acne; and Exelderm, offered as a topical cream and solution. Furthermore, the company distributes doxycycline hyclate tablets, minocycline hydrochloride capsules, and sulconazole nitrate cream and solution.

Valuation in context

P/E ratio
-16.5
N/A
Not meaningful — company is unprofitable
P/B ratio
5.5
Around average
Around the 10-year average
FCF Yield
-4.0%
Above average
Above the 10-year average
Free · No credit card needed

Get alerted when DERM is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.